KIT and acute myeloid leukemia: HLA-DR, CD34, and CD117 also contributed to the separation of leukemic cells from inv(16) AML from those of the MLL AML group, followed by CD64, CD13, and CD11b markers and SSC, FSC parameters (Figure 5).